Description Of Business Segments (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2012		Sep. 30, 2011		Sep. 30, 2012		Sep. 30, 2011
Consolidated Net Sales	$ 5,246		$ 5,382		$ 15,756		$ 15,670
Total Operating Profit	783		662		2,237		1,831
Interest income	4		5		13		13
Interest expense	(70)		(70)		(212)		(205)
Income Before Income Taxes and Equity Interests	717		597		2,038		1,639
Restructuring charges, before tax	31		95		85		267
Non-deductible business tax charge							32
Personal Care [Member]
Consolidated Net Sales	2,414		2,390		7,196		6,918
Total Operating Profit	436		396		1,241		1,185
Consumer Tissue [Member]
Consolidated Net Sales	1,605		1,711		4,852		5,054
Total Operating Profit	216		206		652		529
Restructuring charges, before tax	31		81		80		233
K-C Professional And Other [Member]
Consolidated Net Sales	822		863		2,458		2,477
Total Operating Profit	144		127		407		360
Restructuring charges, before tax	0		14		5		34
Health Care [Member]
Consolidated Net Sales	396		407		1,212		1,186
Total Operating Profit	59		56		168		159
Other (Income) And Expense, Net [Member]
Total Operating Profit	(5)		(17)		(15)		(27)
Corporate And Other [Member]
Consolidated Net Sales	9		11		38		35
Total Operating Profit	$ (77)	[1]	$ (140)	[1]	$ (246)	[1]	$ (429)	[1]

[1] Corporate & Other includes pulp and tissue restructuring charges as follows: Three Months Ended September 30 Nine Months EndedSeptember 30 2012 2011 2012 2011 (Millions of dollars)Consumer Tissue$31 $81 $80 $233K-C Professional & Other— 14 5 34Total$31 $95 $85 $267 See additional information in Note 3 for the pulp and tissue restructuring actions. The nine months ended September 30, 2011 also includes a non-deductible business tax charge of $32 million related to a law change in Colombia.